Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin energy balance in type 2 diabetes
ISRCTN14818531Phase 4Completed
- Sponsor
- University of Liverpool
- Start
- Aug 2015
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of dapagliflozin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by University of Liverpool. Started Aug 2015; status: completed.
02
Drugs
dapagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ISRCTN14818531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14818531.